Getting to the Root of the Matter for BioPharma Quality Issues
Nuala Calnan and Rob de la Espriella investigate how BioPharma can learn ways to prevent recurring events and ineffective CAPA from the nuclear power sector.
top of page
Search
bottom of page
Borrowing root-cause frameworks from high-reliability sectors like commercial nuclear power is such a necessary paradigm shift for BioPharma—too many organizations treat CAPA as a bureaucratic box-ticking exercise rather than an operational discipline. Eliminating human-error repeat deviations requires diagnosing underlying organizational drift and systemic triggers rather than simply prescribing more refresher training. That insistence on foundational integrity, high-spec quality control, and zero-defect consistency is what underpins excellence across high-stakes engineering as well as modern bespoke manufacturing and women's fashion and style . Excellent, critical research from Dr. Calnan and Rob de la Espriella!